[Congressional Record Volume 163, Number 168 (Wednesday, October 18, 2017)]
[Senate]
[Page S6555]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1227. Mr. McCAIN (for himself and Ms. Klobuchar) submitted an 
amendment intended to be proposed to amendment SA 1116 proposed by Mr. 
Enzi to the concurrent resolution H. Con. Res. 71, establishing the 
congressional budget for the United States Government for fiscal year 
2018 and setting forth the appropriate budgetary levels for fiscal 
years 2019 through 2027; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO LOWERING 
                   THE COST OF PRESCRIPTION DRUGS IN THE UNITED 
                   STATES BY IMPORTING DRUGS FROM CANADA.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     lowering the cost of prescription drugs in the United States 
     by importing drugs from Canada, by the amounts provided in 
     such legislation for those purposes, provided that such 
     legislation would not increase the deficit over either the 
     period of the total of fiscal years 2018 through 2022 or the 
     period of the total of fiscal years 2018 through 2027.
                                 ______